Condition: Asthma
Interventions: Drug: Indacaterol acetate 75 ?g; Drug: Indacaterol acetate 150 ?g
Sponsor: Novartis Pharmaceuticals
Not yet recruiting – verified August 2016
View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days